Nicholas Wagar

Title: Innovations in HIV-1 Genotyping by Inventor Nicholas Wagar

Introduction

Nicholas Wagar is a notable inventor based in Decatur, GA (US). He has made significant contributions to the field of HIV research, particularly in the development of genotyping assays for drug resistance surveillance. With a total of 2 patents, his work is crucial for improving healthcare outcomes in resource-poor settings.

Latest Patents

Wagar's latest patents focus on an HIV-1 genotyping assay designed for global surveillance of HIV-1 drug resistance. The methods, primers, and kits he developed are aimed at genotyping HIV-1, including group M viral strains. These innovative methods enhance the ability to monitor drug resistance, especially in regions with limited resources. The disclosed techniques can detect a more diverse mixed HIV-1 population compared to previous methods. This high efficiency in genotyping diverse HIV-1 group M viral strains from plasma and dried blood spot (DBS) samples, along with substantial reagent cost savings, makes these methods applicable for both antiretroviral therapy (ART)-naive and -experienced populations.

Career Highlights

Wagar is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the understanding and management of HIV-1 drug resistance.

Collaborations

Wagar has collaborated with notable colleagues such as Chunfu Yang and Zhiyong Zhou, contributing to the collective effort in HIV research and innovation.

Conclusion

Nicholas Wagar's contributions to HIV-1 genotyping represent a significant advancement in the field, particularly for drug resistance surveillance. His innovative methods are poised to make a lasting impact on global health initiatives.